Shanghai Micurx Pharmaceutical Co.,Ltd. Posted 56.2 Million Yuan Net Loss in First Quarter of 2023

Shanghai Micurx Pharmaceutical Co.,Ltd. (上海盟科药业股份有限公司) (688373.SH) reported a net loss of 56.2 million yuan in the first quarter of 2023, widening 10% year-on-year.

Meanwhile, the company posted 17.3 million yuan in revenue, up 61.7% year-on-year.

At the end of the reporting period, it had 1.4 billion yuan in total assets and 273 million yuan in total liabilities, with a liability-to-asset ratio of 19%.